Costly Medicine

Littlehales, Crispin
April 2007
Red Herring;4/30/2007, Vol. 4 Issue 16, p24
Trade Publication
The article focuses on issues related to the amount of money spent on medical research to develop different drugs for the treatment of various diseases. Thousands of organizations have battled disease of all kinds, and hundreds of billions of taxpayer and investment dollars have backed their efforts. Yet 30 years of biotechnology research have yielded little to stop mankind's biggest killers, including heart disease, cancer and AIDS. Although there has been progress in the lives of people because of these research, modern medicine has treatments for just a third of the 30,000 diseases known today.


Related Articles

  • Ticker Watch. Taylor, Marisa // Red Herring;4/30/2007, Vol. 4 Issue 16, p33 

    The article presents information on the experimental drug AGI-1067, being tested by Alpharetta, Georgia-based biotechnology company Atherogenics, to treat heart disease. The drug aimed to curb inflammatory response, and pharmaceutical giant AstraZeneca went into partnership to push it along....

  • New ideas and dark holes. Delaney, Martis // Advocate;1/12/93, Issue 620, p49 

    Comments on the need to make some real changes in the way the U.S. government funds AIDS research. Development of new approaches to AIDS treatment; Scientists' identification of simpler mechanisms for blocking the attachment of HIV to cells; Importance of providing funds to studies that turn...

  • FEAR FACTORS.  // Prevention;Sep2006, Vol. 58 Issue 9, p47 

    A chart illustrating the five greatest health fears reported by American women, and the actual top five causes of death is presented. Heart disease is the only overlapping item. Fears also include HIV/AIDS and Alzheimer's. Actual causes of death also include stroke and lung cancer.

  • Metaphors for illness in contemporary media. Hanne, M.; Hawken, S. J. // Medical Humanities;Dec2007, Vol. 33 Issue 2, p93 

    Essayist Susan Sontag alerted us more than 20 years ago to the way in which clusters of metaphors attach themselves to our discussion of certain diseases, and the influence these metaphors exert on public attitudes to the diseases themselves and to those who experience them. This study of...

  • IN BRIEF.  // Nature Reviews Drug Discovery;Nov2003, Vol. 2 Issue 11, p862 

    Presents news briefs related to drug development. Discovery by Kamal et al. of why inhibitors of heat-shock protein 90 (Hsp90) can selectively kill cancer cells; Potential for homology models based on available representative protein structures to provide compensation for a lack of X-ray...

  • parallel track:. Huber, Jeffrey T.; Gillaspy, Mary L. // Encyclopedic Dictionary of AIDS-Related Terminology;2000, p172 

    An encyclopedia entry for "parallel track" is presented. Parallel track refers to the condition of an alternative track for the administration of experimental drugs to those individuals who do not qualify for clinical studies. This alternative program is the result of the hearings of the...

  • Pfizer Abandons Heart Drug Development. Faloon, William // Life Extension;Nov2009, Vol. 15 Issue 11, p1 

    The article reports on the announcement given by Pfizer Inc., the largest drug company in the world, that it will no longer develop drugs that prevent or treat atherosclerotic heart disease. According to the company, they wanted to concentrate new drug research on more profitable areas like...

  • D.H.Lawrence's dis-Ease:Examining the Symptoms of "Illness as metaphor". Ruderman, Judith // D.H. Lawrence Review;2011, Vol. 36 Issue 2, p72 

    An essay is presented on the identification of several physical illnesses such as tuberculosis (TB), cancer, heart disease, AIDS and other disorders. It offers a history of TB that was considered as a symbolic aspect associated with an individual and the society in the early 20th century and...

  • Anti-HIV agent hints at vaccine.  // TCE: The Chemical Engineer;Apr2015, Issue 886, p8 

    The article discusses research by Michael Farzan published in an issue of "Nature," which created a novel, potent anti-HIV drug candidate that may be able to act as vaccine.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics